東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Pulmonary embolism = from acute PE t...

Rivera-Lebron, Belinda.

Linked to FindBook

Google Book

Amazon

博客來

Pulmonary embolism = from acute PE to chronic complications /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Pulmonary embolism/ edited by Belinda Rivera-Lebron, Gustavo A. Heresi.
Reminder of title:	from acute PE to chronic complications /
other author:	Rivera-Lebron, Belinda.
Published:	Cham :Springer International Publishing : : 2020.,
Description:	viii, 218 p. :ill., digital ;24 cm.
[NT 15003449]:	Epidemiology of Pulmonary Embolism -- PE Diagnosis -- Risk Stratification of Acute PE -- Bleeding Risk Considerations Prior to Initiation and Duration of Anticoagulation Therapy for the Treatment of Venous Thromboembolism -- Treatment for Pulmonary Embolism: Anticoagulation Selection and Duration -- Indications for systemic thrombolysis over anticoagulation -- Endovascular techniques in the treatment of acute PE -- Role of surgical embolectomy and ECMO in PE -- Inferior Vena Cava filters in Venous Thromboembolism - Multidisciplinary PE response team (PERT) development and implementation -- Post-PE Management -- Epidemiology and Diagnosis of Chronic Thromboembolic Pulmonary Hypertension -- Medical, Endovascular and Surgical Treatment of CTEPH.
Contained By:	Springer Nature eBook
Subject:	Pulmonary embolism. -
Online resource:	https://doi.org/10.1007/978-3-030-51736-6
ISBN:	9783030517366

Pulmonary embolism = from acute PE to chronic complications /
Pulmonary embolismfrom acute PE to chronic complications /[electronic resource] :edited by Belinda Rivera-Lebron, Gustavo A. Heresi. - Cham :Springer International Publishing :2020. - viii, 218 p. :ill., digital ;24 cm. - Respiratory medicine,2197-7372. - Respiratory medicine..

Epidemiology of Pulmonary Embolism -- PE Diagnosis -- Risk Stratification of Acute PE -- Bleeding Risk Considerations Prior to Initiation and Duration of Anticoagulation Therapy for the Treatment of Venous Thromboembolism -- Treatment for Pulmonary Embolism: Anticoagulation Selection and Duration -- Indications for systemic thrombolysis over anticoagulation -- Endovascular techniques in the treatment of acute PE -- Role of surgical embolectomy and ECMO in PE -- Inferior Vena Cava filters in Venous Thromboembolism - Multidisciplinary PE response team (PERT) development and implementation -- Post-PE Management -- Epidemiology and Diagnosis of Chronic Thromboembolic Pulmonary Hypertension -- Medical, Endovascular and Surgical Treatment of CTEPH.

This book is a comprehensive guide to the diagnosis and management of all stages of pulmonary embolism, starting with acute and ending with chronic thromboembolic pulmonary hypertension. Acute pulmonary embolism (PE) is responsible for 150-250,000 hospitalizations and 60-100,000 deaths each year in the United States, making it the third most common cause of cardiovascular death. Acute PE spans a wide spectrum of clinical outcomes mainly based on the right ventricle's (RV) capacity to tolerate strain. There have been many recent advances in the field of PE, including guidelines on classification and risk stratification, anticoagulation, as well as evolving areas in treatment options and follow up. The text begins with a review of the epidemiology and risk factors for PE. Chapters then delve into reviewing the decision pathways based on PE severity and treatment options, including the use of oral anticoagulation, systemic and catheter-directed thrombolysis, mechanical and surgical thrombectomy, and hemodynamic support with extracorporeal membrane oxygenation. The text then focuses on post-PE complications such as post-PE syndrome, chronic thromboembolic disease, and chronic thromboembolic pulmonary hypertension (CTEPH) This is an ideal guide for providers of lung health, including pulmonary and critical care physicians, cardiologists, thoracic and cardiovascular surgeons. Physician-trainees, physician assistants, nurses and respiratory therapists with interest in pulmonary disorders, cardiovascular disease, pulmonary embolism, critical care or pulmonary hypertension will also find great value in this comprehensive guide.

ISBN: 9783030517366

Standard No.: 10.1007/978-3-030-51736-6doiSubjects--Topical Terms:

2017019
Pulmonary embolism.

LC Class. No.: RC766.P85

Dewey Class. No.: 616.249

Pulmonary embolism = from acute PE to chronic complications /
LDR:03445nmm a2200337 a 4500 001 2256105
003 DE-He213
005 20201229092631.0
006 m d
007 cr nn 008maaau
008 220420s2020 sz s 0 eng d
020 $a 9783030517366 $q (electronic bk.)
020 $a 9783030517359 $q (paper)
024 7 $a 10.1007/978-3-030-51736-6 $2 doi
035 $a 978-3-030-51736-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC766.P85
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
072 7 $a MJL $2 thema
082 0 4 $a 616.249 $2 23
090 $a RC766.P85 $b P982 2020
245 0 0 $a Pulmonary embolism $h [electronic resource] : $b from acute PE to chronic complications / $c edited by Belinda Rivera-Lebron, Gustavo A. Heresi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2020.
300 $a viii, 218 p. : $b ill., digital ; $c 24 cm.
490 1 $a Respiratory medicine, $x 2197-7372
505 0 $a Epidemiology of Pulmonary Embolism -- PE Diagnosis -- Risk Stratification of Acute PE -- Bleeding Risk Considerations Prior to Initiation and Duration of Anticoagulation Therapy for the Treatment of Venous Thromboembolism -- Treatment for Pulmonary Embolism: Anticoagulation Selection and Duration -- Indications for systemic thrombolysis over anticoagulation -- Endovascular techniques in the treatment of acute PE -- Role of surgical embolectomy and ECMO in PE -- Inferior Vena Cava filters in Venous Thromboembolism - Multidisciplinary PE response team (PERT) development and implementation -- Post-PE Management -- Epidemiology and Diagnosis of Chronic Thromboembolic Pulmonary Hypertension -- Medical, Endovascular and Surgical Treatment of CTEPH.
520 $a This book is a comprehensive guide to the diagnosis and management of all stages of pulmonary embolism, starting with acute and ending with chronic thromboembolic pulmonary hypertension. Acute pulmonary embolism (PE) is responsible for 150-250,000 hospitalizations and 60-100,000 deaths each year in the United States, making it the third most common cause of cardiovascular death. Acute PE spans a wide spectrum of clinical outcomes mainly based on the right ventricle's (RV) capacity to tolerate strain. There have been many recent advances in the field of PE, including guidelines on classification and risk stratification, anticoagulation, as well as evolving areas in treatment options and follow up. The text begins with a review of the epidemiology and risk factors for PE. Chapters then delve into reviewing the decision pathways based on PE severity and treatment options, including the use of oral anticoagulation, systemic and catheter-directed thrombolysis, mechanical and surgical thrombectomy, and hemodynamic support with extracorporeal membrane oxygenation. The text then focuses on post-PE complications such as post-PE syndrome, chronic thromboembolic disease, and chronic thromboembolic pulmonary hypertension (CTEPH) This is an ideal guide for providers of lung health, including pulmonary and critical care physicians, cardiologists, thoracic and cardiovascular surgeons. Physician-trainees, physician assistants, nurses and respiratory therapists with interest in pulmonary disorders, cardiovascular disease, pulmonary embolism, critical care or pulmonary hypertension will also find great value in this comprehensive guide.
650 0 $a Pulmonary embolism. $3 2017019
650 0 $a Respiratory organs $x Diseases. $3 783035
650 0 $a Critical care medicine. $3 833067
650 1 4 $a Pneumology/Respiratory System. $3 894348
650 2 4 $a Intensive / Critical Care Medicine. $3 894417
650 2 4 $a Cardiology. $3 861477
700 1 $a Rivera-Lebron, Belinda. $3 3526132
700 1 $a Heresi, Gustavo A. $3 3526133
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Respiratory medicine. $3 1566170
856 4 0 $u https://doi.org/10.1007/978-3-030-51736-6
950 $a Medicine (SpringerNature-11650)